Hitting old targets better and identifying new targets

被引：10

作者：

Chen, Yu ^{[1
,2
]}

Scher, Howard I. ^{[1
,2
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA

[2] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA

来源：

NATURE REVIEWS CLINICAL ONCOLOGY | 2012年 / 9卷 / 02期

关键词：

PROSTATE-CANCER; MORTALITY;

D O I：

10.1038/nrclinonc.2011.213

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Options to treat late-stage castration-resistant prostate cancer continued to increase in 2011, as three agents with different mechanisms of action prolonged life and a fourth reduced the morbidity of skeletal metastases. These outcomes contrasted with the heightened controversy generated by the recommendation against PSA screening and other early detection strategies. Chen, Y. & Scher, H. I. Nat. Rev. Clin. Oncol. 9, 70-72 (2012); published online 10 January 2012; doi:10.1038/nrclinonc.2011.213

引用

页码：70 / 72

页数：3

共 50 条

[1] Blood pressure targets in the very old
Farrell, Barbara
Monahan, Anne
Dore, Naomi
Walsh, Kate
CANADIAN FAMILY PHYSICIAN, 2014, 60 (07) : E350 - E355
[2] Strategies for Identifying Molecular Targets for Cancer Chemoprevention
Bode, Ann M.
Dong, Zigang
PROGRESS IN CHEMISTRY, 2013, 25 (09) : 1501 - 1516
[3] A New Role for an Old Drug: Metformin Targets MicroRNAs in Treating Diabetes and Cancer
Zhou, Joseph Yi
Xu, Biao
Li, Lixin
DRUG DEVELOPMENT RESEARCH, 2015, 76 (06) : 263 - 269
[4] Individualising target-controlled anaesthesia. Better models or better targets?
Kennedy, R. R.
ANAESTHESIA AND INTENSIVE CARE, 2010, 38 (03) : 421 - 423
[5] Treatment Targets in Atrial Fibrillation "Is Feeling Better Good Enough?"
Kim, Michael H.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (04) : 461 - 462
[6] Lower Is Not Always Better? Blood Pressure Treatment Targets Revisited
Andersson, Charlotte
Vasan, Ramachandran S.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (06) : 598 - 600
[7] Hitting the Mark: Blood Pressure Targets and Agents in Those With Prevalent Cardiovascular Disease and Heart Failure
Rifkin, Dena E.
Kiernan, Michael
Sarnak, Mark J.
ADVANCES IN CHRONIC KIDNEY DISEASE, 2015, 22 (02) : 140 - 144
[8] Discovery of new therapeutic targets in ovarian cancer through identifying significantly non-mutated genes
Al-Farsi, Halema
Al-Azwani, Iman
Malek, Joel A.
Chouchane, Lotfi
Rafii, Arash
Halabi, Najeeb M.
JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)
[9] Bone metabolism and new targets for intervention
Akduman B.
Crawford E.D.
Current Urology Reports, 2007, 8 (3) : 233 - 238
[10] New molecular targets in bone metastases
Santini, D.
Galluzzo, S.
Zoccoli, A.
Pantano, F.
Fratto, M. E.
Vincenzi, B.
Lombardi, L.
Gucciardino, C.
Silvestris, N.
Riva, E.
Rizzo, S.
Russo, A.
Maiello, E.
Colucci, G.
Tonini, G.
CANCER TREATMENT REVIEWS, 2010, 36 : S6 - S10

← 1 2 3 4 5 →